NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

核酸分離、精製的全球市場 - 各產品種類、各用途、各終端用戶、各地區、各國分析 (2021年版):考察、競爭、預測,新型冠狀病毒感染疾病 (COVID-19)的影響 (2021∼2026年)

Global Nucleic Acid Isolation and Purification Market - Analysis By Product Type, Application, End-User, By Region, By Country (2021 Edition): Market Insights, Covid -19 Impact, Competition and Forecast (2021-2026)

出版商 Azoth Analytics 商品編碼 997437
出版日期 內容資訊 英文 220 Pages
訂單完成後即時交付
價格
核酸分離、精製的全球市場 - 各產品種類、各用途、各終端用戶、各地區、各國分析 (2021年版):考察、競爭、預測,新型冠狀病毒感染疾病 (COVID-19)的影響 (2021∼2026年) Global Nucleic Acid Isolation and Purification Market - Analysis By Product Type, Application, End-User, By Region, By Country (2021 Edition): Market Insights, Covid -19 Impact, Competition and Forecast (2021-2026)
出版日期: 2021年03月31日內容資訊: 英文 220 Pages
簡介

全球核酸分離、精製的市場規模,2020年預計達到33億5984萬美元。市場主要促進因素,是研究開發 (R&D) 投資的增額和技術進步的成果,自動化的發展等。另一方面,自動化設備的價格高也有妨礙市場成長的可能性。各產品種類中各種套件成為最大的市場區隔,以及各地區中北美各國為最大市場。還有亞太地區預計今後有迅速的市場成長。

本報告提供全球核酸分離、精製市場相關分析,市場概要和基本結構,主要的推動及阻礙市場要素,市場規模趨勢預測 (2016年∼2020年/2021年∼2026年),各產品種類、各用途、各終端用戶詳細趨勢,各地區、主要國家的市場結構、趨勢,主要企業的簡介、市場佔有率等調查。

目錄

第1章 分析方法、摘要整理

第2章 策略建議

第3章 核酸分離、精製市場:各產品的未來展望

第4章 全球核酸分離、精製市場:市場規模的測量與預測

  • 市場規模 (以金額為準,2021年∼2026年)

第5章 全球核酸分離、精製市場:各市場區隔分析 (2016年∼2026年)

  • 競爭模式:各產品種類
    • 高套件:市場規模與其預測 (2016年∼2026年)
    • 試劑:市場規模與其預測 (2016年∼2026年)
    • 設備:市場規模與其預測 (2016年∼2026年)
  • 競爭模式:用途的各類型
    • 診斷:市場規模與其預測 (2016年∼2026年)
    • 藥物研發、臨床實驗:市場規模與其預測 (2016年∼2026年)
    • 個人化醫療:市場規模與其預測 (2016年∼2026年)
    • 農業、動物研究:市場規模與其預測 (2016年∼2026年)
    • 其他:市場規模與其預測 (2016年∼2026年)
  • 競爭模式:各終端用戶
    • 醫院、診斷中心:市場規模與其預測 (2016年∼2026年)
    • 教育、研究機關:市場規模與其預測 (2016年∼2026年)
    • 製藥、生物科技企業:市場規模與其預測 (2016年∼2026年)
    • 其他:市場規模與其預測 (2016年∼2026年)

第6章 全球核酸分離、精製市場:各地區的分析

  • 競爭模式:各地區

第7章 北美的核酸分離、精製市場分析 (2016年∼2026年)

  • 市場規模與其預測 (以金額為準,2016年∼2026年)
  • 主要企業
  • 各產品種類的市場區隔 (高套件,試劑,設備)
  • 用途的各種類的市場區隔 (診斷,藥物研發、臨床實驗,個人化醫療,農業、動物研究等)
  • 各終端用戶的市場區隔 (醫院、診斷中心,教育、研究機關,製藥、生物科技企業,其他)
  • 北美的核酸分離、精製市場:各國分析
  • 市場機會表:各國 (以金額為準,2026年)
  • 競爭方案:各國
  • 美國市場
  • 加拿大市場
    • 市場規模與其預測 (以金額為準,2016年∼2026年)
    • 市場規模:各產品種類、用途的各類型、各終端用戶的明細 (2016年∼2026年)

第8章 歐洲的核酸分離、精製市場分析 (2016年∼2026年)

  • 德國市場
  • 法國市場
  • 英國市場
  • 義大利市場

第9章 亞太地區的核酸分離、精製市場分析 (2016年∼2026年)

  • 中國市場
  • 日本市場
  • 印度市場
  • 韓國市場

第10章 全球核酸分離、精製市場:市場動態

  • 促進因素
  • 阻礙因素
  • 趨勢

第11章 市場向心力

  • 全球核酸分離、精製市場向心力 (插圖說明):各產品種類 (2026年)
  • 全球核酸分離、精製市場向心力 (插圖說明):用途的各類型 (2026年)
  • 全球核酸分離、精製市場向心力 (插圖說明):各終端用戶 (2026年)
  • 全球核酸分離、精製市場向心力 (插圖說明):各地區 (2026年)

第12章 競爭情形

  • 主要的技術創新,企業合併、收購 (M&A),各製造公司所扮演的角色
  • 市場佔有率分析

第13章 法規遵守

第14章 企業簡介(營業內容,財務分析,事業策略)

  • QIAGEN
  • Illumina Inc.
  • Danaher
  • F. Hoffman Roche Ltd.
  • Merck KGaA
  • Thermo Fisher Scientific Inc.
  • Agilent Technologies
  • Bio-Rad Laboratories Inc.
  • Promega Corporation
  • Norgen Biotek Corp.
目錄

Executive Summary

Global Nucleic Acid Isolation and Purification Market was valued at USD 3359.84 Million in the year 2020. The growth of this market can majorly be attributed to the increasing R&D activities as well as technological advancements and increasing automation. However, the high cost of automated instruments is expected to hinder the growth of the market. The market for nucleic acid isolation and purification is expected to grow significantly in the coming years, owing to the key factors such as growing advancements in clinical diagnostic techniques, increasing public-private funding for life science research and increasing automation across the globe.

Nucleic acid isolation and purification is essential for a variety of medical applications such as drug discovery, research and others. The need for high quality, highly pure nucleic acid such as DNA and RNA are an essential for a wide variety of research and clinical applications.

Kits accounted for the largest share of the market among product type segment. Growth in this market can be attributed to the low cost and easy usage of kits in applications such as gene sequencing, molecular diagnostics, and gene cloning. On the other hand, the instruments segment is expected to register the highest CAGR during the forecast period. Additionally, Reagents will be followed by High kits and Instruments will also boost the nucleic acid isolation and purification market in coming years.

Among the regions, North America accounted for the largest share of the nucleic acid isolation and purification market in 2020. Factors such as significant R&D spending in biotechnology and pharmaceutical companies, technological advancements, and government support are the key factors driving the growth of the nucleic acid isolation and purification market in North America. On the other hand, the Asia Pacific region is expected to grow at the highest CAGR during the forecast period.

Scope of the Report

  • The report analyses Nucleic Acid Isolation and Purification Market By Value.
  • The report analyses Nucleic Acid Isolation and Purification Market Product Type (High Kits, Reagents, Instruments).
  • The report further assesses the Nucleic Acid Isolation and Purification Market By Application Type (Diagnostics, Drug Discovery & Development, Personalized Medicine, Agriculture & Animal Research, Others).
  • The report further assesses the Nucleic Acid Isolation and Purification Market By End User (Hospitals &Diagnostic Centers, Academic & Research Institutes, Pharmaceuticals & Biotechnology Companies, Others)
  • The Global Nucleic Acid Isolation and Purification Market has been analysed By Region (North America, Europe, Asia Pacific and ROW) and By Country (United States, Canada, Germany, France, U.K, Italy, China, Japan, India, South Korea).
  • The key insights of the report have been presented through the frameworks of Major Mergers & Acquisitions, Technological Innovations, and Role of Manufacturers during COVID Pandemic. Also, the attractiveness of the market has been presented By Region, By Product, By Application, and By End User. Additionally, the major opportunities, trends, drivers and challenges of the industry has been analysed in the report.
  • The companies analysed in the report include QIAGEN, Illumina Inc., Danaher, F. Hoffman-La Roche Ltd., Merck KGaA, Thermo Fisher Scientific Inc., Agilent Technologies, Bio-Rad Laboratories Inc., Promega Corporation, Norgen Biotek Corp.
  • The report presents the analysis of Nucleic Acid Isolation and Purification Market for the historical period of 2016-2020 and the forecast period of 2021-2026.

Key Target Audience

  • Research Institutions
  • Healthcare and Pharmaceutical Companies
  • Hospitals and Healthcare Units
  • Consulting and Advisory Firms
  • Investment Banks and Equity Firms

Table of Contents

1. Research Methodology and Executive Summary

  • 1.1 Research Methodology
  • 1.2 Executive Summary

2. Strategic Recommendations

3. Nucleic Acid Isolation and Purification Market: Product Outlook

4. Global Nucleic Acid Isolation and Purification Market: Sizing and Forecast

  • 4.1 Market Size, By Value, Year 2021-2026

5. Global Nucleic Acid Isolation and Purification Market Segmentation: An Analysis (2016-2026)

  • 5.1 Competitive Scenario of Global Nucleic Acid Isolation and Purification Market: By Product Type
    • 5.1.1 High Kits n Market Size and Forecast (2016-2026)
    • 5.1.2 Reagents n Market Size and Forecast (2016-2026)
    • 5.1.3 Instruments n Market Size and Forecast (2016-2026)
  • 5.2 Competitive Scenario of Global Nucleic Acid Isolation and Purification Market: By Application Type
    • 5.2.1 Diagnostics n Market Size and Forecast (2016-2026)
    • 5.2.2 Drug Discovery & Development n Market Size and Forecast (2016-2026)
    • 5.2.3 Personalized Medicine n Market Size and Forecast (2016-2026)
    • 5.2.4 Agriculture & Animal Research n Market Size and Forecast (2016-2026)
    • 5.2.5 Others n Market Size and Forecast (2016-2026)
  • 5.3 Competitive Scenario of Global Nucleic Acid Isolation and Purification Market: By End user
    • 5.3.1 Hospitals & Diagnostic Centers - Market Size and Forecast (2016-2026)
    • 5.3.2 Academic & Research Institutes - Market Size and Forecast (2016-2026)
    • 5.3.3 Pharmaceuticals & Biotechnology Companies - Market Size and Forecast (2016-2026)
    • 5.3.4 Others n Market Size and Forecast (2016-2026)

6. Global Nucleic Acid Isolation and Purification Market: Regional Analysis

  • 6.1 Competitive Scenario of Global Nucleic Acid Isolation and Purification Market: By Region

7. North America Nucleic Acid Isolation and Purification Market: An Analysis (2016-2026)

  • 7.1 North America Nucleic Acid Isolation and Purification Market: Size and Forecast (2016-2026), By Value
  • 7.2 North America Nucleic Acid Isolation and Purification Market - Prominent Companies
  • 7.3 Market Segmentation By Product Type (High Kits, Reagents and Instruments)
  • 7.4 Market Segmentation By Application Type (Diagnostics, Drug Discovery & Development, Personalized Medicine, Agriculture & Animal Research and Others)
  • 7.5 Market Segmentation By End User (Hospitals & Diagnostic Centers, Academic & Research Institutes, Pharmaceuticals & Biotechnology Companies and Others)
  • 7.6 North America Nucleic Acid Isolation and Purification Market: Country Analysis
  • 7.7 Market Opportunity Chart of North America Nucleic Acid Isolation and Purification Market - By Country, By Value, 2026
  • 7.8 Competitive Scenario of North America Nucleic Acid Isolation and Purification Market: By Country
  • 7.9 United States Nucleic Acid Isolation and Purification Market: Size and Forecast (2016-2026), By Value
  • 7.10 United States Medical Nucleic Acid Isolation and Purification Market Segmentation - By Product Type, By Application Type and By End User (2016-2026)
  • 7.11 Canada Nucleic Acid Isolation and Purification Market: Size and Forecast (2016-2026), By Value
  • 7.12 Canada Nucleic Acid Isolation and Purification Market Segmentation - By Product Type, By Application Type and By End User (2016-2026)

8. Europe Nucleic Acid Isolation and Purification Market: An Analysis (2016-2026)

  • 8.1 Europe Nucleic Acid Isolation and Purification Market: Size and Forecast (2016-2026), By Value
  • 8.2 Europe Nucleic Acid Isolation and Purification Market - Prominent Companies
  • 8.3 Market Segmentation By Product Type ( High Kits, Reagents and Instruments)
  • 8.4 Market Segmentation By Application Type (Diagnostics, Drug Discovery & Development, Personalized Medicine, Agriculture & Animal Research and Others)
  • 8.5 Market Segmentation By End User (Hospitals & Diagnostic Centers, Academic & Research Institutes, Pharmaceuticals & Biotechnology Companies and Others)
  • 8.6 Europe Nucleic Acid Isolation and Purification Market: Country Analysis
  • 8.7 Market Opportunity Chart of Europe Nucleic Acid Isolation and Purification Market - By Country, By Value, 2026
  • 8.8 Competitive Scenario of Europe Nucleic Acid Isolation and Purification Market : By Country
  • 8.9 Germany Nucleic Acid Isolation and Purification Market: Size and Forecast (2016-2026), By Value
  • 8.10 Germany Medical Nucleic Acid Isolation and Purification Market Segmentation - By Product Type, By Application Type and By End User (2016-2026)
  • 8.11 France Nucleic Acid Isolation and Purification Market: Size and Forecast (2016-2026), By Value
  • 8.12 France Nucleic Acid Isolation and Purification Market Segmentation - By Product Type, By Application Type and By End User (2016-2026)
  • 8.13 United Kingdom Nucleic Acid Isolation and Purification Market: Size and Forecast (2016-2026), By Value
  • 8.14 United Kingdom Medical Nucleic Acid Isolation and Purification Market Segmentation - By Product Type, By Application Type and By End User (2016-2026)
  • 8.15 Italy Nucleic Acid Isolation and Purification Market: Size and Forecast (2016-2026), By Value
  • 8.16 Italy Nucleic Acid Isolation and Purification Market Segmentation - By Product Type, By Application Type and By End User (2016-2026)

9. Asia Pacific Nucleic Acid Isolation and Purification Market: An Analysis (2016-2026)

  • 9.1 Asia Pacific Nucleic Acid Isolation and Purification Market: Size and Forecast (2016-2026), By Value
  • 9.2 Asia Pacific Nucleic Acid Isolation and Purification Market - Prominent Companies
  • 9.3 Market Segmentation By Product Type ( High Kits, Reagents and Instruments)
  • 9.4 Market Segmentation By Application Type (Diagnostics, Drug Discovery & Development, Personalized Medicine, Agriculture & Animal Research and Others)
  • 9.5 Market Segmentation By End User (Hospitals & Diagnostic Centers, Academic & Research Institutes, Pharmaceuticals & Biotechnology Companies and Others)
  • 9.6 Asia Pacific Nucleic Acid Isolation and Purification Market: Country Analysis
  • 9.7 Market Opportunity Chart of Asia Pacific Nucleic Acid Isolation and Purification Market - By Country, By Value, 2025
  • 9.8 Competitive Scenario of Asia Pacific Nucleic Acid Isolation and Purification Market : By Country
  • 9.9 China Nucleic Acid Isolation and Purification Market: Size and Forecast (2016-2026), By Value
  • 9.10 China Medical Nucleic Acid Isolation and Purification Market Segmentation - By Product Type, By Application Type and By End User (2016-2026)
  • 9.11 Japan Nucleic Acid Isolation and Purification Market: Size and Forecast (2016-2026), By Value
  • 9.12 Japan Nucleic Acid Isolation and Purification Market Segmentation - By Product Type, By Application Type and By End User (2016-2026)
  • 9.13 India Nucleic Acid Isolation and Purification Market: Size and Forecast (2016-2026), By Value
  • 9.14 India Medical Nucleic Acid Isolation and Purification Market Segmentation - By Product Type, By Application Type and By End User (2016-2026)
  • 9.15 South Korea Nucleic Acid Isolation and Purification Market: Size and Forecast (2016-2026), By Value
  • 9.16 South Korea Nucleic Acid Isolation and Purification Market Segmentation - By Product Type, By Application Type and By End User (2016-2026)

10. Global Nucleic Acid Isolation and Purification Market Dynamics

  • 10.1 Drivers
  • 10.2 Restraints
  • 10.3 Trends

11. Market Attractiveness

  • 11.1 Market Attractiveness Chart of Global Nucleic Acid Isolation and Purification Market - By Product Type, 2026
  • 11.2 Market Attractiveness Chart of Global Nucleic Acid Isolation and Purification Market - By Application Type, 2026
  • 11.3 Market Attractiveness Chart of Global Nucleic Acid Isolation and Purification Market - By End User, 2026
  • 11.4 Market Attractiveness Chart of Global Nucleic Acid Isolation and Purification Market - By Region, 2026

12. Competitive Landscape

  • 12.1 Major Technological Innovations, Mergers & Acquisitions and Role of Manufacturers
  • 12.2 Market Share Analysis

13. Regulatory Compliance

14. Company Profiles (Business Description, Financial Analysis, Business Strategy)

  • 14.1 QIAGEN
  • 14.2 Illumina Inc.
  • 14.3 Danaher
  • 14.4 F. Hoffman Roche Ltd.
  • 14.5 Merck KGaA
  • 14.6 Thermo Fisher Scientific Inc.
  • 14.7 Agilent Technologies
  • 14.8 Bio-Rad Laboratories Inc.
  • 14.9 Promega Corporation
  • 14.10 Norgen Biotek Corp.

List of Figures

  • Figure 1: Global Nucleic Acid Isolation and Purification Market Size, By Value, 2016-2026 (USD Million)
  • Figure 2: Global Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
  • Figure 3: Global Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
  • Figure 4: Global Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
  • Figure 5: Global Number of deaths in 2020, all cancers, males and females, all ages, (In Numbers)
  • Figure 6: Global Financial Stimulus Package Provided By Government, By Countries, 2020
  • Figure 7: Global Number of Intensive Care Beds, 2020 (In Numbers)
  • Figure 8: Global Number of Confirmed COVID19 Deaths, Feb 2021 (In Per Million People)
  • Figure 9: Global Nucleic Acid Isolation and Purification Market, By Product, 2020, 2026
  • Figure 10: Global Nucleic Acid Isolation and Purification Market n By High Kits, By Value (USD Million), 2016-2026
  • Figure 11: Global Nucleic Acid Isolation and Purification Market n By Reagents, By Value (USD Million), 2016-2026
  • Figure 12: Global Nucleic Acid Isolation and Purification Market n By Instruments, By Value (USD Million), 2016-2026
  • Figure 13: Global Nucleic Acid Isolation and Purification Market, By Application, 2020, 2026
  • Figure 14: Global Nucleic Acid Isolation and Purification Market n By Diagnostics, By Value (USD Million), 2016-2026
  • Figure 15: Global Nucleic Acid Isolation and Purification Market n By Drug Discovery & Development, By Value (USD Million), 2016-2026
  • Figure 16: Global Nucleic Acid Isolation and Purification Market n By Personalized Medicine, By Value (USD Million), 2016-2026
  • Figure 17: Global Nucleic Acid Isolation and Purification Market n By Agriculture & Animal Research, By Value (USD Million), 2016-2026
  • Figure 18: Global Nucleic Acid Isolation and Purification Market n By Others, By Value (USD Million), 2016-2026
  • Figure 19: Global Nucleic Acid Isolation and Purification Market, By End User, 2020, 2026
  • Figure 20: Global Nucleic Acid Isolation and Purification Market n By Hospitals & Diagnostic Centers, By Value (USD Million), 2016-2026
  • Figure 21: Global Nucleic Acid Isolation and Purification Market n By Academic & Research Institute, By Value (USD Million), 2016-2026
  • Figure 22: Global Nucleic Acid Isolation and Purification Market n By Pharmaceuticals & Biotechnology Companies, By Value (USD Million), 2016-2026
  • Figure 23: Global Nucleic Acid Isolation and Purification Market n By Others, By Value (USD Million), 2016-2026
  • Figure 24: Global Nucleic Acid Isolation and Purification Market, By Region, 2020, 2026
  • Figure 25: North America Nucleic Acid Isolation & Purification Market Size, By Value, 2016-2026 (USD
  • Figure 26: North America Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
  • Figure 27: North America Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
  • Figure 28: North America Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
  • Figure 29: North America Number of deaths in 2020, all cancers, males and females, all ages, (In Numbers)
  • Figure 30: North America Number of Intensive Care Beds, 2020 (In Numbers)
  • Figure 31: North America Number of Confirmed COVID19 Deaths, Feb 2021 (In Per Million People)
  • Figure 32: North America Nucleic Acid Isolation & Purification Market n By Product, By Value, 2016-2026 (USD Million)
  • Figure 33: North America Nucleic Acid Isolation & Purification Market n By Application, By Value, 2016-2026 (USD Million)
  • Figure 34: North America Nucleic Acid Isolation & Purification Market - By End User, By Value, 2016-2026 (USD Million)
  • Figure 35: Market Opportunity Chart of North America Nucleic Acid Isolation and Purification Market - By Country, By Value, 2026
  • Figure 36: North America Nucleic Acid Isolation and Purification Market, By Country, 2020, 2026
  • Figure 37: United State Nucleic Acid Isolation & Purification Market Size, By Value, 2016-2026 (USD Million)
  • Figure 38: United State Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
  • Figure 39: United State Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
  • Figure 40: United State Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
  • Figure 41: United StateNumber of deaths in 2020, all cancers, males and females, all ages, (In Numbers)
  • Figure 42: United State Nucleic Acid Isolation & Purification Market n By Product, By Value, 2016-2026 (USD Million)
  • Figure 43: United State Nucleic Acid Isolation & Purification Market n By Application, By Value, 2016-2026 (USD Million)
  • Figure 44: United State Nucleic Acid Isolation & Purification Market - By End User, By Value, 2016-2026 (USD Million)
  • Figure 45: Canada Nucleic Acid Isolation & Purification Market Size, By Value, 2016-2026 (USD Million)
  • Figure 46: Canada Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
  • Figure 47: Canada Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
  • Figure 48: Canada Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
  • Figure 49: Canada Number of deaths in 2020, all cancers, males and females, all ages, (In Numbers)
  • Figure 50: Canada Nucleic Acid Isolation & Purification Market n By Product, By Value, 2016-2026 (USD Million)
  • Figure 51: Canada Nucleic Acid Isolation & Purification Market n By Application, By Value, 2016-2026 (USD Million)
  • Figure 52: Canada Nucleic Acid Isolation & Purification Market - By End User, By Value, 2016-2026 (USD Million)
  • Figure 53: Europe Nucleic Acid Isolation & Purification Market Size, By Value, 2016-2026 (USD Million)
  • Figure 54: Europe Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
  • Figure 55: Europe Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
  • Figure 56: Europe Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
  • Figure 57: Europe Number of deaths in 2020, all cancers, males and females, all ages, (In Numbers)
  • Figure 58: Europe Number of Intensive Care Beds, 2020 (In Numbers)
  • Figure 59: Europe Number of Confirmed COVID19 Deaths, Feb 2021 (In Per Million People)
  • Figure 60: Europe Nucleic Acid Isolation & Purification Market n By Product, By Value, 2016-2026 (USD Million)
  • Figure 61: Europe Nucleic Acid Isolation & Purification Market n By Application, By Value, 2016-2026 (USD Million)
  • Figure 62: Europe Nucleic Acid Isolation & Purification Market - By End User, By Value, 2016-2026 (USD Million)
  • Figure 63: Market Opportunity Chart of Europe Nucleic Acid Isolation and Purification Market - By Country, By Value, 2026
  • Figure 64: Europe Nucleic Acid Isolation and Purification Market, By Country, 2020, 2026
  • Figure 65: Germany Nucleic Acid Isolation & Purification Market Size, By Value, 2016-2026 (USD Million)
  • Figure 66: Germany Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
  • Figure 67: Germany Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
  • Figure 68: Germany Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
  • Figure 69: Germany Number of deaths in 2020, all cancers, males and females, all ages, (In Numbers)
  • Figure 70: Germany Nucleic Acid Isolation & Purification Market n By Product, By Value, 2016-2026 (USD Million)
  • Figure 71: Germany Nucleic Acid Isolation & Purification Market n By Application, By Value, 2016-2026 (USD Million)
  • Figure 72: Germany Nucleic Acid Isolation & Purification Market - By End User, By Value, 2016-2026 (USD Million)
  • Figure 73: France Nucleic Acid Isolation & Purification Market Size, By Value, 2016-2026 (USD Million)
  • Figure 74: France Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
  • Figure 75: France Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
  • Figure 76: France Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
  • Figure 77: France Number of deaths in 2020, all cancers, males and females, all ages, (In Numbers)
  • Figure 78: France Nucleic Acid Isolation & Purification Market n By Product, By Value, 2016-2026 (USD Million)
  • Figure 79: France Nucleic Acid Isolation & Purification Market n By Application, By Value, 2016-2026 (USD Million)
  • Figure 80: France Nucleic Acid Isolation & Purification Market - By End User, By Value, 2016-2026 (USD Million)
  • Figure 81: United Kingdom Nucleic Acid Isolation & Purification Market Size, By Value, 2016-2026 (USD Million)
  • Figure 82: United Kingdom Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
  • Figure 83: United Kingdom Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
  • Figure 84: United Kingdom Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
  • Figure 85: United Kingdom Number of deaths in 2020, all cancers, males and females, all ages, (In Numbers)
  • Figure 86: United Kingdom Nucleic Acid Isolation & Purification Market n By Product, By Value, 2016-2026 (USD Million)
  • Figure 87: United Kingdom Nucleic Acid Isolation & Purification Market n By Application, By Value, 2016-2026 (USD Million)
  • Figure 88: United Kingdom Nucleic Acid Isolation & Purification Market - By End User, By Value, 2016-2026 (USD Million)
  • Figure 89: Italy Nucleic Acid Isolation & Purification Market Size, By Value, 2016-2026 (USD Million)
  • Figure 90: Italy Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
  • Figure 91: Italy Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
  • Figure 92: Italy Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
  • Figure 93: Italy Number of deaths in 2020, all cancers, males and females, all ages, (In Numbers)
  • Figure 94: Italy Nucleic Acid Isolation & Purification Market n By Product, By Value, 2016-2026 (USD Million)
  • Figure 95: Italy Nucleic Acid Isolation & Purification Market n By Application, By Value, 2016-2026 (USD Million)
  • Figure 96: Italy Nucleic Acid Isolation & Purification Market n By Application, By Value, 2016-2026 (USD Million)
  • Figure 97: Asia Pacific Nucleic Acid Isolation & Purification Market Size, By Value, 2016-2026 (USD Million)
  • Figure 98: Asia Pacific Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
  • Figure 99: Asia Pacific Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
  • Figure 100: Asia Pacific Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
  • Figure 101: Asia Pacific Number of deaths in 2020, all cancers, males and females, all ages, (In Numbers)
  • Figure 102: Asia Number of Intensive Care Beds, 2020 (In Numbers)
  • Figure 103: Asia pacific Number of Confirmed COVID19 Deaths, Feb 2021 (In Per Million People)
  • Figure 104: Asia Pacific Nucleic Acid Isolation & Purification Market n By Product, By Value, 2016-2026 (USD Million)
  • Figure 105: Asia Pacific Nucleic Acid Isolation & Purification Market n By Application, By Value, 2016-2026 (USD Million)
  • Figure 106: Asia Pacific Nucleic Acid Isolation & Purification Market - By End User, By Value, 2016-2026 (USD Million)
  • Figure 107: Market Opportunity Chart of Asia Pacific Nucleic Acid Isolation and Purification Market - By Country, By Value, 2026
  • Figure 108: Asia Pacific Nucleic Acid Isolation and Purification Market, By Country, 2020, 2026
  • Figure 109: China Nucleic Acid Isolation & Purification Market Size, By Value, 2016-2026 (USD Million)
  • Figure 110: China Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
  • Figure 111: China Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
  • Figure 112: China Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
  • Figure 113: China Number of deaths in 2020, all cancers, males and females, all ages, (In Numbers)
  • Figure 114: China Nucleic Acid Isolation & Purification Market n By Product, By Value, 2016-2026 (USD Million)
  • Figure 115: China Nucleic Acid Isolation & Purification Market n By Application, By Value, 2016-2026 (USD Million)
  • Figure 116: China Nucleic Acid Isolation & Purification Market - By End User, By Value, 2016-2026 (USD Million)
  • Figure 117: Japan Nucleic Acid Isolation & Purification Market Size, By Value, 2016-2026 (USD Million)
  • Figure 118: Japan Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
  • Figure 119: Japan Current Healthcare Expenditure as percentage of GDP, 2015-2018 (In %)
  • Figure 120: Japan Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
  • Figure 121: Japan Number of deaths in 2020, all cancers, males and females, all ages, (In Numbers)
  • Figure 122: Japan Nucleic Acid Isolation & Purification Market n By Product, By Value, 2016-2026 (USD Million)
  • Figure 123: Japan Nucleic Acid Isolation & Purification Market n By Application, By Value, 2016-2026 (USD Million)
  • Figure 124: Japan Nucleic Acid Isolation & Purification Market - By End User, By Value, 2016-2026 (USD Million)
  • Figure 125: India Nucleic Acid Isolation & Purification Market Size, By Value, 2016-2026 (USD Million)
  • Figure 126: India Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
  • Figure 127: India Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
  • Figure 128: India Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
  • Figure 129: India Number of deaths in 2020, all cancers, males and females, all ages, (In Numbers)
  • Figure 130: India Nucleic Acid Isolation & Purification Market n By Product, By Value, 2016-2026 (USD Million)
  • Figure 131: India Nucleic Acid Isolation & Purification Market n By Application, By Value, 2016-2026 (USD Million)
  • Figure 132: India Nucleic Acid Isolation & Purification Market - By End User, By Value, 2016-2026 (USD Million)
  • Figure 133: South Korea Nucleic Acid Isolation & Purification Market Size, By Value, 2016-2026 (USD Million)
  • Figure 134: South Korea Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
  • Figure 135: South Korea Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
  • Figure 136: South Korea Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
  • Figure 137: South Korea Number of deaths in 2020, all cancers, males and females, all ages, (In Numbers)
  • Figure 138: South Korea Nucleic Acid Isolation & Purification Market n By Product, By Value, 2016-2026 (USD Million)
  • Figure 139: South Korea Nucleic Acid Isolation & Purification Market n By Application, By Value, 2016-2026 (USD Million)
  • Figure 140: South Korea Nucleic Acid Isolation & Purification Market - By End User, By Value, 2016-2026 (USD Million)
  • Figure 141: Market Attractiveness of Global Nucleic Acid Isolation and Purification Market - By Product Type, 2026
  • Figure 142: Market Attractiveness of Global Nucleic Acid Isolation and Purification Market n By Application, 2026
  • Figure 143: Market Attractiveness Chart of Global Nucleic Acid Isolation and Purification Market - By End User, 2026
  • Figure 144: Market Attractiveness Chart of Global Nucleic Acid Isolation and Purification Market - By Region, 2026
  • Figure 145: Market Share of Leading Global Nucleic Acid Isolation and Purification Companies, 2019 (In %)
  • Figure 146: Qiagen Revenue, 2015-2019 (In USD Million)
  • Figure 147: Qiagen Revenue, By Business Segment, 2018 (In %)
  • Figure 148: Qiagen Revenue, By Business Segment, 2019 (In %)
  • Figure 149: Qiagen Net Revenue, By Region, 2018 (In %)
  • Figure 150: Qiagen Net Revenue, By Region, 2019 (In %)
  • Figure 151: Illumina Inc. Revenue, 2016-2019 (In USD Million)
  • Figure 152: Illumina Inc. Net Revenue, By Business Segment, 2018 (In %)
  • Figure 153: Illumina Inc. Net Revenue, By Business Segment, 2019 (In %)
  • Figure 154: Illumina Inc. Net Revenue, By Region, 2018 (In %)
  • Figure 155: Illumina Inc. Net Revenue, By Region, 2019 (In %)
  • Figure 156: Danaher Revenue, 2015-2019 (In USD Million)
  • Figure 157: Danaher Net Revenue, By Business Segment, 2018 (In %)
  • Figure 158: Danaher Net Revenue, By Business Segment, 2019 (In %)
  • Figure 159: Danaher Net Revenue, By Geographic Segment, 2018 (In %)
  • Figure 160: Danaher Net Revenue, By Geographic Segment, 2019 (In %)
  • Figure 161: F. Hoffman-La Roche Ltd Revenue, 2015-2019 (In USD Million)
  • Figure 162: F. Hoffman-La Roche Net Sales, By Business Segment, 2018 (In %)
  • Figure 163: F. Hoffman-La Roche Net Sales, By Business Segment, 2019 (In %)
  • Figure 164: Merck KGaA Revenue, 2015-2019 (In USD Million)
  • Figure 165: Merck KGaA Net Sales, By Business Segment, 2018 (In %)
  • Figure 166: Merck KGaA Net Sales, By Business Segment, 2019 (In %)
  • Figure 167: Merck KGaA Net Sales, By Geographical Region, 2018 (In %)
  • Figure 168: Merck KGaA Net Sales, By Geographical Region, 2019 (In %)
  • Figure 169: Thermo Fisher Scientific Inc. Revenue, 2015-2019 (In USD Million)
  • Figure 170: Thermo Fisher Scientific Inc Net Sales, By Business Segment, 2018 (In %)
  • Figure 171: Thermo Fisher Scientific Inc Net Sales, By Business Segment, 2019 (In %)
  • Figure 172: Thermo Fisher Scientific Inc Net Sales, By Geographical Region, 2018 (In %)
  • Figure 173: Thermo Fisher Scientific Inc Net Sales, By Geographical Region, 2019 (In %)
  • Figure 174: Agilent Technologies Revenue, 2015-2019 (In USD Million)
  • Figure 175: Agilent Technologies Net Sales, By Business Segment, 2018 (In %)
  • Figure 176: Agilent Technologies Net Sales, By Business Segment, 2019 (In %)
  • Figure 177: Bio-Rad Laboratories Inc. Revenue, 2015-2019 (In USD Million)
  • Figure 178: Bio-Rad Laboratories Inc. Net Sales, By Business Segment, 2018 (In %)
  • Figure 179: Bio-Rad Laboratories Inc. Net Sales, By Business Segment, 2019 (In %)
  • Figure 180: Bio-Rad Laboratories Inc. Net Sales, By Geographical Region, 2018 (In %)
  • Figure 181: Bio-Rad Laboratories Inc. Net Sales, By Geographical Region, 2019 (In %)